Regeneron Pharmaceuticals
REGN
REGN
1,160 hedge funds and large institutions have $66.1B invested in Regeneron Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 88 funds opening new positions, 397 increasing their positions, 465 reducing their positions, and 107 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
15% less repeat investments, than reductions
Existing positions increased: 397 | Existing positions reduced: 465
18% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 107
33% less funds holding in top 10
Funds holding in top 10: 42 → 28 (-14)
Holders
1,160
Holding in Top 10
28
Calls
$1.45B
Puts
$1.68B
Top Buyers
| 1 | +$577M | |
| 2 | +$144M | |
| 3 | +$98M | |
| 4 |
Man Group
London,
United Kingdom
|
+$83.8M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$80.6M |
Top Sellers
| 1 | -$1.33B | |
| 2 | -$239M | |
| 3 | -$201M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$193M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$181M |